Holy Cross Health is Enrolling Patients in a Colorectal Cancer Trial
April 20, 2021 – Holy Cross Health is now enrolling patients in a colorectal cancer trial (BESPOKE CRC), a prospective, multi-center trial that will enroll 1,000 or more patients at the time of surgery to measure the clinical impact of serial blood-based testing with Signatera, earlier relapse detection, and better patient risk stratification after surgery.
Read More















